The EPHA2 gene helps cells send signals that keep tissues organized, especially the clear lens of the eye. If it does not work properly, the lens can become cloudy, which may lead to cataracts and blurred vision, either from birth or later in life. This gene helps your body maintain the shape and stability of lens cells so light passes through more clearly. Some variants in the EPHA2 gene are linked to inherited cataracts, while others may modestly influence cataract risk with age.
What is a gene?
A gene is a stretch of DNA that holds instructions your cells use to make molecules or regulate processes in the body. Some genes provide the information needed to produce proteins, the parts of cells that do the work. Other genes mainly help direct when certain processes happen, where they happen, and how strongly they run. Together, genes affect how the body develops and works, and they can also influence how you respond to food, stress, or medications. If you want to go into this topic in more detail, you can find more in the LearnHub.
Overview
EPHA2Gene function
What if the gene works
The EPHA2 gene helps cells communicate at their surfaces. It supports how tissues are organized and is especially important for keeping the eye’s lens clear.
Risk
What if the gene does not work
Variants in the EPHA2 gene can disrupt how the eye lens stays clear. They are best known for causing inherited cataracts or increasing age related cataract risk, with effects ranging from mild later clouding to dense cataracts at birth.
Treatment
What does that mean for your treatment
No treatment or management approach is currently tailored to pathogenic variants in the EPHA2 gene in clinical guidelines. The EPHA2 gene is being studied as a possible drug target and biomarker in several cancers, but this has not yet changed routine treatment choices.
Conditions associated with EPHA2
Gene function
What if the gene works
EPHA2 helps nearby cells communicate when they touch. Those signals guide how cells line up, stay in place, and move in a coordinated way. This supports the normal structure of tissues throughout the body.
The EPHA2 gene makes a surface protein that receives signals from nearby cells through partner proteins called ephrins. These contact based messages help cells respond to their neighbors.
EPHA2 signaling helps cells sort into the right places and form clean borders with nearby groups. This supports normal tissue shape during growth and everyday upkeep.
Signals from the EPHA2 gene help cells adjust their shape and grip as they move. This makes movement more coordinated during development and healing.
In the eye lens, the EPHA2 gene helps lens cells stay neatly packed and aligned. This well known EPHA2 gene function in the eye lens supports normal clarity.
What is a variant?
A genetic variant is a minor difference in the DNA sequence within a gene. These differences are common and help explain normal human diversity, including variation in appearance, metabolism, and the way the body reacts to environmental factors. Many have no visible effect and are simply part of natural genetic variation. In some situations, though, a variant can change how a gene works more strongly and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Many EPHA2 gene variants change the receptor’s shape or stability, so it may not reach the cell surface properly or pass signals between lens cells in a controlled way. Inherited EPHA2 gene variants and cataracts are linked because these changes can disrupt how lens cells stay aligned and clear. Some variants mildly reduce signaling, while more disruptive variants can sharply impair the protein and are often tied to earlier or denser cataracts.
How variants are linked to conditions
Variants in the EPHA2 gene are most clearly linked to cataracts, including congenital cataracts that may be present at birth or appear in childhood. In some families, a pathogenic EPHA2 variant can cause an inherited cataract and help confirm the diagnosis. More common changes in the EPHA2 gene have also been associated with a higher chance of age-related cataracts, especially cortical cataracts, but these risk-linked variants do not mean cataracts will definitely develop.
A variant is not necessarily a diagnosis
Genetic variants are a routine part of human biology and are widespread in the general population. Most do not have a direct effect on health and simply reflect normal human diversity. For many genes, having a variant associated with a condition points to a possible link rather than a definite diagnosis, especially when several genes and environmental factors are involved. In some situations, though, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For inherited cataracts linked to the EPHA2 gene, the gene change itself is usually the main driver, and family history matters most. For age-related cataracts, other factors such as getting older, smoking, diabetes, and long-term sun exposure can add to overall risk.
Inheritance of EPHA2 variants
For families asking how EPHA2 variants are inherited, the pattern can differ depending on the specific variant and cataract type. Variants in the EPHA2 gene are most often linked to inherited cataracts that follow an autosomal dominant pattern, which means a parent carrying the variant can pass it to each child with a 50% chance. Some EPHA2-related cataracts have also been reported with autosomal recessive inheritance, where a child inherits one altered copy from each parent. Because of that, EPHA2 inheritance is not described by one single pattern for every family.
What does my EPHA2 result mean for my family?
EPHA2 changes are best known for some inherited cataracts, and the family impact depends on the specific result because both dominant and recessive patterns have been reported. In families with a dominant EPHA2 change, close relatives such as a parent, brother, sister, or child may also carry it and may want to discuss testing. In families with a recessive EPHA2 change, parents are often healthy carriers, and brothers or sisters may also be carriers or, less often, affected.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a change in the EPHA2 gene, a lab can analyze DNA from a blood sample, saliva, or cheek swab as part of EPHA2 genetic testing for inherited cataracts. The test reads the gene’s spelling and looks for variants, then specialists classify any finding as pathogenic, likely pathogenic, benign, or uncertain.
When should I consider getting a genetic test?
Genetic testing for the EPHA2 gene may be worth considering if a baby is born with cataracts, if cataracts develop unusually early, or if several family members have had them. In these settings, testing can help show whether an inherited change in EPHA2 is the cause and whether it may run in the family.
A genetic result is only one part of your health story
Genetic results can provide meaningful insight, but how much they explain varies by the condition and the specific type of variant. Many factors, including lifestyle, environment, age, and medical history, also shape how the body works over time. For some conditions, especially those influenced by many genes, genetic information gives context rather than certainty and is most useful when viewed alongside other parts of care. In other situations, a genetic result can offer a clear answer. In areas like medication response, genetic findings may help place individual experiences in context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Two people can take the same treatment at the same dose, yet one may get a stronger effect, less benefit, or more side effects because their bodies break down, move, or respond to the drug differently. These inherited differences are common and are one reason medication response can vary from person to person.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences shape a person’s response to medications. By looking at the relationship between genes and drugs, it helps explain why the same treatment may work differently from one person to another. For many medicines, genes can affect both how strongly a drug works and how the body processes it. This information can support treatment decisions that are more informed and more individualized. More detailed information on this topic is available in the LearnHub.
Drugs influenced by the EPHA2 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding everyday medication choices, so general questions about side effects, treatment changes, or how well a medicine is working are best discussed with your doctor. In cancer research, EPHA2 has been studied as a possible marker of response to some targeted treatments, but this is not part of routine prescribing.
History
EPHA2 entered genetics research in the early 1990s as scientists were sorting out the larger EPH family of genes, a group named after findings in a human liver cell line called erythropoietin producing hepatocellular carcinoma. Researchers then mapped the EPHA2 gene and studied where it was active in the body, which helped place it within a growing picture of cell signaling genes. From these first observations, research expanded steadily. In the 2000s, EPHA2 drew more clinical attention when variants in the gene were linked to inherited cataracts and later to age related cataracts in broader populations. Over time, this shifted EPHA2 from a mainly laboratory finding to a gene with clearer medical relevance in eye health.